89.75USD+2.17%Mkt Cap: 6.14B USDP/E: —Last update: 2026-05-26
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United States and internationally. The company's lead product candidate is IMCIVREE (setmelan…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap6.14B USD
Enterprise Value6.07B USD
Revenue (TTM)217.16M USD
Gross Profit170.26M USD
Net Income (TTM)-196.54M USD
Revenue/Share3.280 USD
Last Price89.75 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees414
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-79.34
PEG—
EV/EBITDA-30.93
EV/Revenue27.94
P/S28.46
P/B43.59
EPS (TTM)-3.13
EPS (Forward)-1.14
52W Range
58.7249% of range122.20
52W High122.20 USD
52W Low58.72 USD
Profitability
Gross Margin89.73%
Oper. Margin-87.11%
EBITDA Margin-90.33%
Profit Margin-103.57%
ROE-72.79%
ROA-40.93%
Growth
Revenue Growth83.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-115.67M USD
CapEx (TTM)953.00K USD
FCF Margin-69.38%
FCF Yield-2.45%
Net Debt-228.32M USD
Net Debt/EBITDA1.16
Balance Sheet
Debt/Equity0.01
Current Ratio4.17
Quick Ratio3.63
Book Value/Sh2.069 USD
Cash/Share4.970 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)138.20 USD
Target Range105.00 USD – 159.00 USD
# Analysts15
Ownership
Shares Out.68.53M
Float55.70M
Insiders0.77%
Institutions110.00%
Short Interest
Short Ratio11.9d
Short % Float11.85%
Short % Out.11.76%
Shares Short8.06M
Short (prev mo.)7.62M
Technical
SMA 5087.13 (+3.0%)
SMA 20098.67 (-9.0%)
Beta1.94
S&P 52W Chg28.31%
Avg Vol (30d)705.08K
Avg Vol (10d)758.08K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—